ATE27739T1 - Praeparat zur diagnose von chlamydia-infektionen und zur gewinnung der chlamydiagruppespezifischen antikoerper. - Google Patents
Praeparat zur diagnose von chlamydia-infektionen und zur gewinnung der chlamydiagruppespezifischen antikoerper.Info
- Publication number
- ATE27739T1 ATE27739T1 AT83106453T AT83106453T ATE27739T1 AT E27739 T1 ATE27739 T1 AT E27739T1 AT 83106453 T AT83106453 T AT 83106453T AT 83106453 T AT83106453 T AT 83106453T AT E27739 T1 ATE27739 T1 AT E27739T1
- Authority
- AT
- Austria
- Prior art keywords
- chlamydia
- group
- diagnosis
- specific antibodies
- chlamydial
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 241000606161 Chlamydia Species 0.000 title 1
- 208000007190 Chlamydia Infections Diseases 0.000 title 1
- 208000028512 chlamydia infectious disease Diseases 0.000 title 1
- 206010061041 Chlamydial infection Diseases 0.000 abstract 2
- 241000498849 Chlamydiales Species 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 229930186217 Glycolipid Natural products 0.000 abstract 1
- 241000588770 Proteus mirabilis Species 0.000 abstract 1
- 241001222774 Salmonella enterica subsp. enterica serovar Minnesota Species 0.000 abstract 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000001962 electrophoresis Methods 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- 230000035931 haemagglutination Effects 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000405 serological effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56927—Chlamydia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/50—Lipopolysaccharides; LPS
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/879—Salmonella
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/823—Immunogenic carrier or carrier per se
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI822348A FI69639C (fi) | 1982-07-02 | 1982-07-02 | Preparat foer anvaendning vid klamydia-diagnostik |
| EP83106453A EP0098557B1 (de) | 1982-07-02 | 1983-07-01 | Präparat zur Diagnose von Chlamydia-Infektionen und zur Gewinnung der Chlamydiagruppe-spezifischen Antikörper |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE27739T1 true ATE27739T1 (de) | 1987-06-15 |
Family
ID=8515769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT83106453T ATE27739T1 (de) | 1982-07-02 | 1983-07-01 | Praeparat zur diagnose von chlamydia-infektionen und zur gewinnung der chlamydiagruppespezifischen antikoerper. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4652518A (de) |
| EP (1) | EP0098557B1 (de) |
| JP (1) | JPS5927261A (de) |
| AT (1) | ATE27739T1 (de) |
| AU (1) | AU1649283A (de) |
| CA (1) | CA1230551A (de) |
| DE (2) | DE98557T1 (de) |
| DK (1) | DK304483A (de) |
| FI (1) | FI69639C (de) |
| NO (1) | NO832407L (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4818817A (en) * | 1983-11-30 | 1989-04-04 | Petroleum Fermentations N.V. | Enzymatic degradation of lipopolysaccharide bioemulsifiers |
| CA1212051A (en) * | 1984-03-02 | 1986-09-30 | John W. Cherwonogrodzky | Identification of brucella abortus and brucellosis infection |
| GB8416841D0 (en) * | 1984-07-03 | 1984-08-08 | Technology Licence Co Ltd | Monoclonal antibodies |
| GB8426468D0 (en) * | 1984-10-19 | 1984-11-28 | Technology Licence Co Ltd | Monoclonal antibodies |
| GB8427006D0 (en) * | 1984-10-25 | 1984-11-28 | Iq Bio Ltd | Determination of chlamydia trachomatis |
| US4918163A (en) * | 1985-09-27 | 1990-04-17 | Pfizer Inc. | Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria |
| US5179001A (en) * | 1985-09-27 | 1993-01-12 | The Regents Of The University Of California | Detection and monitoring of chronic and gram-negative infection |
| ES2009366A6 (es) * | 1986-04-24 | 1989-09-16 | Univ California | Procedimiento de obtencion de anticuerpos monoclonales para bacterias gram-negativas. |
| CA1336576C (en) * | 1986-09-26 | 1995-08-08 | Malcolm B. Perry | Immunoassays for discriminating between brucellosis infections and vaccinations |
| CA1335563C (en) * | 1987-08-13 | 1995-05-16 | Synbiotics Corporation | Amphipathic analyte assays using lipophilic surface |
| US4916057A (en) * | 1988-02-29 | 1990-04-10 | Kallestad Diagnostics, Inc. | Chlamydia assay employing base treatment |
| FR2631125A1 (fr) * | 1988-05-06 | 1989-11-10 | Pasteur Institut | Procede de detection directe de chlamydiae, anticorps monoclonaux anti-chlamydiae et leurs applications au diagnostic des infections chlamydiales |
| US5089479A (en) * | 1988-11-28 | 1992-02-18 | Krivan Howard C | Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
| US5484706A (en) * | 1993-05-19 | 1996-01-16 | Pasteur Sanofi Diagnostics | Immunoassay for analytes in samples using alkylating agents |
| AU660268B3 (en) * | 1993-07-16 | 1995-06-15 | Deakin University | Bacteria-specific lipopolysaccharide-like molecules |
| US5773234A (en) * | 1995-08-07 | 1998-06-30 | Quidel Corporation | Method and device for chlamydia detection |
| JPH10339731A (ja) * | 1997-06-06 | 1998-12-22 | Mitsubishi Chem Corp | 腸管出血性大腸菌感染の検出方法 |
| EP1068532A4 (de) | 1998-04-15 | 2003-07-16 | Univ Utah State | Realzeit-detektion von antikörpern |
| US7220596B2 (en) * | 1998-04-15 | 2007-05-22 | Utah State University | Real time detection of antigens |
| KR101151202B1 (ko) * | 2006-10-12 | 2012-06-11 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 수중유 에멀젼 애주번트를 포함하는 백신 |
| US9452209B2 (en) | 2007-04-20 | 2016-09-27 | Glaxosmithkline Biologicals Sa | Influenza vaccine |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4039657A (en) * | 1975-06-19 | 1977-08-02 | Merck & Co., Inc. | Separating antigen from residual common sensitizing protein |
| US4118469A (en) * | 1976-04-27 | 1978-10-03 | Research Corporation | Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU) |
| US4096035A (en) * | 1977-06-15 | 1978-06-20 | Merck & Co., Inc. | Separation of trachoma agent from growth medium impurities |
| GB2047889A (en) * | 1979-04-02 | 1980-12-03 | Research Corp | Detection of antibodies to chlormydia trachomatis having an immunofluorescence test |
| EP0017460A1 (de) * | 1979-04-02 | 1980-10-15 | Research Corporation | Immunofluoreszenz-Testmethode und Substanz zur Verwendung darin |
| US4310455A (en) * | 1979-04-17 | 1982-01-12 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
| US4267170A (en) * | 1979-09-06 | 1981-05-12 | Seawell Albert C | Methods of using chlamydia vaccine for preventing and treating bovine diseases |
| US4271146A (en) * | 1979-09-06 | 1981-06-02 | Seawell Albert C | Methods of using Chlamydia vaccine for preventing and treating bovine and ovine diseases |
| JPS57501692A (de) * | 1980-09-24 | 1982-09-16 | ||
| US4397959A (en) * | 1980-11-05 | 1983-08-09 | Research Corporation | Forced precipitation method for preparing antigen/antibody particles |
| US4497899A (en) * | 1982-04-12 | 1985-02-05 | Abbott Laboratories | Immunoassay for Chlamydia trachomatis antigens |
-
1982
- 1982-07-02 FI FI822348A patent/FI69639C/fi not_active IP Right Cessation
-
1983
- 1983-06-24 US US06/507,788 patent/US4652518A/en not_active Expired - Fee Related
- 1983-07-01 JP JP58118413A patent/JPS5927261A/ja active Granted
- 1983-07-01 AT AT83106453T patent/ATE27739T1/de not_active IP Right Cessation
- 1983-07-01 DE DE198383106453T patent/DE98557T1/de active Pending
- 1983-07-01 DE DE8383106453T patent/DE3372018D1/de not_active Expired
- 1983-07-01 AU AU16492/83A patent/AU1649283A/en not_active Abandoned
- 1983-07-01 DK DK304483A patent/DK304483A/da unknown
- 1983-07-01 EP EP83106453A patent/EP0098557B1/de not_active Expired
- 1983-07-01 NO NO832407A patent/NO832407L/no unknown
- 1983-07-04 CA CA000431720A patent/CA1230551A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0098557B1 (de) | 1987-06-10 |
| AU1649283A (en) | 1984-01-05 |
| FI822348L (fi) | 1984-01-03 |
| DE3372018D1 (en) | 1987-07-16 |
| EP0098557A2 (de) | 1984-01-18 |
| DK304483A (da) | 1984-01-03 |
| NO832407L (no) | 1984-01-03 |
| JPH0450531B2 (de) | 1992-08-14 |
| DK304483D0 (da) | 1983-07-01 |
| DE98557T1 (de) | 1984-07-05 |
| FI822348A0 (fi) | 1982-07-02 |
| EP0098557A3 (en) | 1984-04-04 |
| FI69639C (fi) | 1986-03-10 |
| CA1230551A (en) | 1987-12-22 |
| JPS5927261A (ja) | 1984-02-13 |
| US4652518A (en) | 1987-03-24 |
| FI69639B (fi) | 1985-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE27739T1 (de) | Praeparat zur diagnose von chlamydia-infektionen und zur gewinnung der chlamydiagruppespezifischen antikoerper. | |
| Dowdle et al. | An indirect hemagglutination test for diagnosis of Mycoplasma pneumoniae infections | |
| Bonner et al. | Evidence for a second chemotactic system in the cellular slime mold, Dictyostelium discoideum | |
| Washburn et al. | Streptococcus sbe: immunological characteristics | |
| Rönnberg et al. | Rapid detection by a coagglutination test of heat-labile enterotoxin in cell lysates from blood agar-grown Escherichia coli | |
| Halter et al. | Lipooligosaccharides from Treponema hyodysenteriae and Treponema innocens | |
| Hurvell | Serological cross-reactions between different Brucella species and Yersinia Enterocolitica immunodiffusion and immunoelectrophoresis | |
| ATE87216T1 (de) | Polyvalentes hyperimmunglobulin-praeparat. | |
| Ormsbee et al. | Studies on Bacterium Tularense Antigens: II. Chemical and Physical Characteristics of Protective Antigen Preparations | |
| Holmberg et al. | Determination of antibodies to pneumococcal C polysaccharide in patients with community-acquired pneumonia | |
| Lancefield et al. | Studies on the Antigenic Composition of Group A Hemolytic Streptococci: II. The Occurrence of Strains in a Given Type Containing M but No T Antigen | |
| McDonough et al. | Interpretations of antibody responses to Salmonella enterica serotype enteritidis gm flagellin in poultry flocks are enhanced by a kinetics-based enzyme-linked immunosorbent assay | |
| Wheeler et al. | Antigenic Complex of Shigella paradysenteriae, Boyd Type P274 | |
| DiPierro et al. | Enzymatic reversibility of flagellar immobilization | |
| Rimler | Coagglutination test for identification of Pasteurella multocida associated with hemorrhagic septicemia | |
| McArthur et al. | Antigenic mimicry of eel tissues by a myxosporidian parasite? | |
| Kawaguchi-Nagata et al. | Immunomodulating activities of staphylococcal enterotoxins I. Effects on in vivo antibody responses and contact sensitivity reaction | |
| Babudieri et al. | The leptospirae of the Italian hedge-hog | |
| Hryniewicz et al. | Comparison of three methods for grouping streptococci | |
| Saphra et al. | Serological relationship amongst Salmonella and other Enterobacteriaceae | |
| Mirick et al. | STUDIES ON A NON-HEMOLYTIC STREPTOCOCCUS ISOLATED FROM THE RESPIRATORY TRACT OF HUMAN BEINGS: III. IMMUNOLOGICAL RELATIONSHIP OF STREPTOCOCCUS MG TO STREPTOCOCCUS SALIVARIUS TYPE I | |
| Bacillus | Immunological Cross-Reactions of Type B Friedländer Bacillus in Type 2 Antipneumococcal Horse and Rabbit Serum | |
| Miyake et al. | Subgroups in group III of RNA phages | |
| Jenkins et al. | Passive hemolysis test for antibody to Treponema hyodysenteriae | |
| Gupta et al. | Use of formalinized sheep erythrocytes in the rubella hemagglutination-inhibition test |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |